DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Epizyme, Inc. (EPZM)
« Back to company indexEPZM Chatter Timeline
Stock Ticker for EPZM
Most Active Tweeters for EPZM
| User | Tweets |
|---|---|
| @1MinuteStock | 17 |
| @Tickeron | 12 |
| @stockmktgenius | 10 |
| @Lin_ling_88 | 10 |
| @newsfilterio | 7 |
Recent Tweets for EPZM
 |
@sikorsj RT @EpizymeRx: #Breaking: @US_FDA grants accelerated approval to $EPZM’s first #oncology product. Read more: https://t.co/G3LKg8WvWD https:… 7:01pm |
|
@touchraazu1 RT @marvinador: Stock to watch tomorrow: $EPZM #stock #fdaapproval #biotech https://t.co/oFVQQXhv8C 6:01pm |
 |
@jeff_cranmer 13 yrs since its founding, $EPZM now has an approved drug, Tazverik tazemetostat, a first-in-class EZH2 inhibitor t… https://t.co/GpR5JRzaQ4 6:01pm |
 |
@marvinador Stock to watch tomorrow: $EPZM #stock #fdaapproval #biotech https://t.co/oFVQQXhv8C 6:01pm |
 |
@Lin_ling_88 $EPZM #OncLive commented on #tazemetostat’s accelerated approval: https://t.co/i2vjgceOfc 6:01pm |
 |
@MarketCurrents $EPZM - FDA approves Epizyme's treatment for epithelioid sarcoma https://t.co/CxAnNyIVne 6:01pm |
 |
@OlympiaReport Epizyme $EPZM Shares Gap Up Following Analyst Upgrade https://t.co/JG6k8mculs 6:01pm |
 |
@dispatchtribune Epizyme $EPZM Shares Gap Up After Analyst Upgrade https://t.co/AB8VR8D9T5 6:01pm |
 |
@realmaciej RT @odibro: $EPZM Announces FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma ht… 6:01pm |
 |
@jonathanrockoff $EPZM wins @US_FDA approval for its rare, soft tissue cancer drug Tazverik, agency says 6:01pm |
 |
@seculare RT @seculare: @MadMoneyOnCNBC $EPZM Tazemetostat is poised for approval this month & expanded approval later this year. With a promising pi… 6:01pm |
 |
@LizCancerHealth RT @NedPagliarulo: $EPZM's tazemetostat approved by FDA for epithelioid sarcoma. Will be sold as Tazverik. Call at 5:30 PM ET https://t.c… 6:01pm |
 |
@BosBizAllison @EpizymeRx It's worth noting that $EPZM has said the drug — which is also awaiting FDA approval as a treatment for… https://t.co/BcTEvX7OYR 5:01pm |
 |
@piealamo This is it??????? $EPZM 5:01pm |
 |
@PinkSheetSutter @US_FDA grants accelerated approval to $EPZM's Tazverik (tazemetostat) for epithelioid sarcoma, in line w/ unanimou… https://t.co/ZtbMeP4Dnu 5:01pm |
 |
@NedPagliarulo Price for $EPZM's tazemetostat is $15,500 for one month supply, per conference call. 5:01pm |
|
@BosBizAllison Breaking: @EpizymeRx's first-ever commercial product for a rare cancer has been approved. It will cost $15,500 per month. $EPZM 5:01pm |
 |
@stockmktgenius $EPZM Epizyme, Inc. - Common St Top stock up 197% from low. Close: 26.72 VolvsAvg: 1.49 Liq: $50M https://t.co/IRQ3Smj1B8 5:01pm |
 |
@TraderMorty RT @zipcharlie: $EPZM gets approved - BUT remember, every reaction is an overreaction. Proceed with caution... #trading https://t.co/UMH6LE… 5:01pm |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $EPZM is $-0.67 it's -2.63% of the current price https://t.co/Xq2g1XlI9e 5:01pm |
 |
@medtechy Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK $EPZM | Medtechy https://t.co/YD5vkLJYSu 5:01pm |
 |
@vernon_veegray1 $EPZM Wasn’t this suppose to go to the moon or something of that nature? 5:01pm |
|
@Lin_ling_88 FDA approves Epizyme's treatment for rare tissue cancer - Reuters $EPZM #tazemetostat approved for epithelioid sar… https://t.co/kUTcGtph9B 5:01pm |
 |
@syinvesting $EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients wit… https://t.co/y7tqodB3S7 5:01pm |
 |
@haodongvli $EPZM was a crowded short last year https://t.co/RsO4bNFjYT 5:01pm |
 |
@otcdynamics $EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients w https://t.co/85jONmNMJp 5:01pm |
 |
@eo1989 RT @TraderTexMex: $EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epit… 5:01pm |
 |
@zipcharlie $EPZM gets approved - BUT remember, every reaction is an overreaction. Proceed with caution... #trading https://t.co/UMH6LEVMO1 5:01pm |
|
@NedPagliarulo $EPZM's tazemetostat approved by FDA for epithelioid sarcoma. Will be sold as Tazverik. Call at 5:30 PM ET https://t.co/wo9inKP8bh 5:01pm |
 |
@TraderTexMex $EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma 5:01pm |
 |
@odibro $EPZM Announces FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid… https://t.co/BcXLGVESqq 5:01pm |
 |
@ScorpioRysing @Lin_ling_88 $EPZM - Hmm, if so, that doesn't bode well. Hoping they get approval, but no dog in this show myself. GLTA. 4:01pm |
|
@Lin_ling_88 $EPZM: @i am pretty sure FDA has informed Epizyme of its decision regarding #tazemetostat ‘s NDA, for reasons know… https://t.co/Og5eQeCBzS 4:01pm |
 |
@androsForm $EPZM money flow chart via SuperStocks App https://t.co/D6orcLyUII 3:01pm |
 |
@shane_adamski RT @zipcharlie: Keep an eye on $EPZM before the FDA decision! We talked about this guy back on Sunday & on the 22nd of Dec. I prefer disapp… 3:01pm |
|
@zipcharlie Keep an eye on $EPZM before the FDA decision! We talked about this guy back on Sunday & on the 22nd of Dec. I prefe… https://t.co/FF55vwzuJK 3:01pm |
|
@1MinuteStock Recommendation #HOLD for $EPZM with UB rating - 2.25 out of 5. https://t.co/LBzC2yV0n2 3:01pm |
 |
@Tickeron $EPZM in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/P6qg3WoCTQ 3:01pm |
 |
@stockmonitorapp RSI just crossed above 70 on $EPZM. Gaining strength! See chart: https://t.co/Jsn3XT6Ffs $COMPQ https://t.co/pUB82Azff1 2:01pm |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $EPZM is $-0.67 it's -2.63% of the current price https://t.co/Xq2g1X47hG 2:01pm |
|
@haodongvli $EPZM 52 wk high, who was selling below $10 a few month ago? 2:01pm |
|
@vernon_veegray1 $EPZM Alright!! Bought a few hundred shares and I’m losing money already! 2:01pm |
 |
@birdmang30 RT @Getrealorelse: $EPZM...fingers crossed...PDUFA today 2:01pm |
 |
@Getrealorelse $EPZM...fingers crossed...PDUFA today 2:01pm |
|
@1MinuteStock Not sure what to do with $EPZM? Explore our #fundamental pros and cons. https://t.co/SnV0Tj9pZr 1:01pm |
 |
@c2412345 $EPZM FDA approval after hours. Wonder if it will go +100% like $AUPH did ? Also a buyout target with a price as h… https://t.co/M5GKvHuyXN 1:01pm |
 |
@TheUnicornBay Do you know that #WallStreet price for $EPZM is $22.63 https://t.co/gXEDFWfyV9 1:01pm |
 |
@OphirGottlieb $EPZM Epizyme shares are trading higher after Citigroup maintained its Buy rating on the stock and raised its price… https://t.co/dZDi1Tq987 10:01am |
 |
@aboutheoptions Trade Ideas $EPZM (delayed) FEB21 30C/20P #strangle - still actionable 9:01am |
 |
@JosePon86089208 $EPZM - Citigroup Maintains Buy on Epizyme, Raises Price Target to $35 9:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.